Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TrønderEnergi becomes the largest shareholder in Scandinavian Biogas

The Norwegian energy company TrønderEnergi has become the largest shareholder in Scandinavian Biogas, a leading producer of biogas in the Nordics. TrønderEnergi as an industrial owner, will provide a long-term perspective and support the growth ambitions of the Company in the biogas market. As part of the transaction, Scandinavian Biogas becomes approximately 97 per cent owner of its Norwegian subsidiary Biokraft Holding AS.TrønderEnergi, owned by 24 municipalities in Norway, the utility NEAS and the Norwegian pension fund KLP, has since early 2016 been a minority shareholder of Biokraft, a

Nomination Committee at Nordic Paper

Nordic Paper’s Nomination Committee shall in accordance with the resolution by the General Meeting consist of one representative of each of the four shareholders controlling the largest number of votes as per the last banking day in October the year before the Annual General Meeting, and which desires to appoint a member of the Nomination Committee. For the period until the 2021 AGM, Nordic Paper’s Nomination Committee will have the following members: Andreas Kihlblom, appointed by Sutriv Holding AB, (Shanying)Patricia Hedelius, appointed by AMF PensionsförsäkringCaroline Sjösten,

Ayima Group AB - Interim Report Q3, 2020

Highlights Q3: Jul - Sep 2020 · EBITDA for the quarter amounted to 4.9MSEK (2.3), a 112%  increase from the corresponding period in 2019 and 174% increase  from Q2 · Profit after tax for the period was 2.1 MSEK (-1.0), a significant turnaround from the corresponding period in 2019 · Gross Profit amounted to 22.5 MSEK (27.3) a decrease of 17.5% from the corresponding period in 2019 but an increase of 23% from the previous quarter (18.3) · Total Revenue for the quarter amounted to 34.0 MSEK (57.8), a decrease of 41% from the corresponding period in 2019 but an increase

NeoDynamics AB (publ) Third Quarter 2020

The proposed financing strengthens NeoDynamics ahead of pivotal periodThird quarter 2020 · There were no sales during the period. Revenue amounted to SEK 2.643 m (4.581 m) including capitalized costs of SEK 2.051 m (4.469 m). · Loss after tax amounted to SEK -6.731 m (-4.416 m). · Loss per share amounted to SEK -0.19 (-0.29). 9 months 2020 · There were no sales during the period. Revenue amounted to SEK 15.175 m (16.329 m), whereof capitalized costs SEK 14.140 m (16 214 m). · Costs for product development contuned to be higher than expected. · Loss after tax

BioStock: CombiGene on the first in vivo study in the lipodystrophy project CGT2

CombiGene reaches a new milestone in its CGT2 project aimed at developing a gene therapy treatment for partial lipodystrophy. A first selection of drug candidates has been made in in vitro experiments with liver cells and the biotechnology company is now taking the next step by initiating in vivo studies to evaluate which protein expression can be achieved in experimental models. BioStock reached out to CombiGene’s CEO Jan Nilsson to learn more about the goal of initiating proof-of-concept studies during 2021.Read the full interview with CombiGene's CEO Jan Nilsson at biostock.se: https:/

“First time in Japan” Introducing the latest anti-viral technology ViralOff®︎ to 5 types of office chairs

(Translated press release from Itoki) Itoki co., Ltd. (Headquarter: Chuo-ku, Tokyo CEO: Yoshiro Hirai) will release five new office chairs with ViralOff®︎, the latest anti-viral treatment technology from Polygiene AB. (Headquarter: Malmo, Sweden CEO: Ulrika Björk), from December 2020. “Our longtime partner Itoki pioneered the office furniture segment when they started using our Stays Fresh solution a number of years ago. And they are now taking the next step by being the first in the world using Polygiene ViralOff in a number of their office chairs, a logic step for this

Dignitana AB Publishes Q3 2020 Interim Report

Consistent growth with increasing opportunity aheadFinancial highlights · Group revenue in Q3 2020 amounted to 12 596 TSEK (10 374 TSEK), an increase of 21 percent over the same period in 2019 and an increase of 6 percent over Q2 2020. · EBITDA in Q3 2020 amounted to -5 284 TSEK (-6 866 TSEK), a decline of losses of 23 percent over the same period in 2019. Losses increased by 4 percent compared to Q2 2020. · Earnings per share in Q3 2020 is -0,18 SEK ( -0,21 SEK). · Average Daily Treatment Revenue (ADTR)* was 107 TSEK (101 TSEK), an increase of 7 percent over the same period

NeoDynamics receives first UK order of pulse biopsy system NeoNavia

NeoDynamics AB (publ, (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, announces today that the Company has received the first UK order from the Buckinghamshire Healthcare NHS Trust, London, of its pulse biopsy system, NeoNavia.Product demonstrations at several centres have gained significant interest, and the company has now received the first commercial order of its pulse biopsy system including three needle options for all ultrasound led biopsy procedures. The UK team of NeoDynamics has managed to introduce physicians at key

Interim Report 1 January 2020 – 30 September 2020

Scandion Oncology A/S (”Scandion Oncology” or “the Company”) hereby publishes the Interim Report for the period 1 January – 30 September 2020. The Interim Report is available on the Company's website (www.scandiononcology.com). Below is a summary of the report.Reporting period July 2020 – September 2020 · Net sales amounted to DKK 0 (0). · Operating profit was -4.90 m DKK (-7.03). · Cash and bank assets amounted to 7.50 m DKK (18.03). · Result per share was DKK -0.20 (-0.33). Reporting period January 2020 – September 2020 · Net sales amounted to DKK 0 (0). ·

Ingka Group receives Blue Sky Award for outstanding contributions to advance sustainable transport

In 2018 Ingka Group announced targets for zero emission home deliveries by 2025. The retailer has also made commitments to build charging infrastructure, transform its fleet and halve emissions from customer and co-worker travel.Ingka Group is working to help bring forth change in the zero emission last mile sphere, by influencing different aspects of the journey – from charging infrastructure and governmental regulations to the actual development of zero emission vehicles. Since the announcement of the target in 2018, the home furnishing company has doubled the share of deliveries being

Read original

Cereno Scientific publishes interim report for Q3 2020 (1 January – 30 September 2020)

The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for the third quarter 2020.Summary of the interim report Cereno Scientific Group Year to date (1 January – 30 September 2020) · Net Sales were 0 SEK · Loss after financial items was SEK 10 907 101 · Loss per share was SEK 0.27 before dilution and SEK 0.25 after dilution · The equity/assets ratio was 86.3 % Third quarter (1 July 2020 – 30 September 2020) · Net Sales were 0 SEK · Loss after financial items was SEK 3 132 513 · Loss per share was SEK 0.08 before

Absolicon wins E-prize - business energy prize

Absolicon wins E-Prize - Sweden's leading energy award for businesses - in the category "renewable energy". Absolicon is awarded the prize for its concentrating solar collector T160, which with sunlight produces heat and steam for district heating networks and industrial processes.E-Prize rewards Swedish companies with the most innovative solutions for climate-friendly energy supply and sustainable transport in the future. Absolicon’s patented and certified solution consisting of concentrating solar collectors that produce heat and steam for district heating networks and for operating

ExpreS2ion announces interim results for the first nine months of 2020

Hørsholm, Denmark, November 19, 2020 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its interim financial results for the first nine months of 2020 and the third quarter of 2020. The Interim Report (Q3) is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “One reason – perhaps the main reason – I am so pleased with our recent capital raise is that we can now finally get to work on the HER2 VLP breast cancer vaccine AV001. There is a good chance that with the investments we make

Carrefour chooses Pricer as preferred ESL supplier for worldwide installations

Pricer announces that the retail group Carrefour has chosen Pricer as preferred  supplier for new ESL (Electronic Shelf Label) installations and upgrading of stores that are already equipped with Pricer’s ESL. Although the framework agreement contains no commitments with regard to volumes or amounts, the intent is to deploy the Pricer system in approximately 500 stores before the end of 2022.The grocery chain Carrefour plans to leverage Pricer’s advanced in-store communication and management system to equip and upgrade all store formats (hypermarkets, supermarkets,  proximity stores and

Delårsrapport 1 JANUARI – 30 SEPTEMBER 2020 FLOWSCAPE TECHNOLOGY AB (publ), ORG.NR. 556725-4866

Styrelsen och verkställande direktören för Flowscape Technology AB avger härmed rapport för perioden januari – september 2020. Belopp anges i tusentals kronor. Siffror inom parentes avser motsvarande period föregående år.Januari – september 2020 i korthet, koncern TREDJE KVARTALET (JULI-SEPTEMBER) · Nettoomsättningen ökade till 8 544 (6 964) TSEK · Rörelseresultat före avskrivningar uppgick till 1 890 (485) TSEK · Resultat efter finansiella poster uppgick till -4 327 (-6 400) TSEK · Kassan vid perioden utgång var 15 021 TSEK jämfört med 2 931 TSEK vid årets inledning. ·

Induct to continue facilitation of the Innovation Indicator project in Norwegian Health Authorities

Induct has been awarded a contract to report on innovation activity and take the lead on a pilot to measure and report on innovation project benefits in all Norwegian health authorities. The contract value is NOK 400.000. excl. VAT. All regional health authorities and hospital trusts that are using the Induct platform will automatically adopt the indicator reporting practice through the Induct platform. "Induct's Healthcare Network currently covers over 90% of Norwegian hospital trusts. The network enables healthcare professionals to find and adopt solutions that other hospitals have

Realfiction Holding AB announces its Q3 Interim Report for July – September 2020

The company announces that the Q3 Interim Report for July – September 2020 is now available. The full report is attached as a separate document and can also be downloaded from the company’s website (www.realfiction.com). A printed copy can be ordered via investor@realfiction.com. Below is a summary of the Q3 Interim Report.Important key figures:• 53% decline in total revenue in Q3, 2020 compared to Q3, 2019• 43% decline in gross profit in Q3, 2020 compared to Q3, 2019• 21% increase (9.7 points) in gross profit margin in Q3, 2020 compared to Q3, 2019• Net operating cost savings of

Interview with CEO in Dagens Börs

Our CEO Hosni Teque-Omeirat was today interviewed by Dagens Börs. Please find it here https://dagensbors.se/intervjun-teque-omeirat-vd-spectrumone/  For further information contact:Fredric ForsmanChairman of the Board +46 73 978 78 44 fredric@spectrumone.com Certified Adviser:Mangold Fondkommission AB (556585-1267) Box 55 691 102 15 Stockholm Telefon: +46 8 503 015 50 ca@mangold.se www.mangold.se  Om SpectrumOne AB SpectrumOne är ett ledande teknikföretag som levererar en avancerad plattformssvit för datahantering, analys och kommunikation. SpectrumOne

Realfiction announces its plan for completion of the ECHO integration license package

Realfiction Holding AB (“Realfiction” and/or “the Company”) announces a completion phase including a potential further optimization for production which is expected to result in even lower manufacturing costs and a slimmer form factor. The completion phase is planned to last 13-16 months in collaboration with a couple of leading European research institutes and facilities. By spring 2021, Realfiction will also actively seek a co-development agreement with a commercial display manufacturer to speed up time to market.As part of the ongoing ECHO development, Realfiction has identified a

Kemira hosts a virtual Capital Markets Day today, November 19, 2020

Kemira Oyj, Press release, November 19, 2020 at 9.05 am (EET) Kemira hosts a virtual Capital Markets Day today, November 19, 2020 Kemira organizes a virtual Capital Markets Day for investors and analysts today, November 19, 2020 at 2 pm – 4 pm EET. The aim of the Capital Markets Day is to provide an overview of Kemira’s progress since the last CMD in 2017 and key future focus areas. President and CEO Jari Rosendal: “Since the last Capital Markets Day in 2017, Kemira has significantly improved profitability. We have taken a lot of action to strengthen the foundation and we are

Eurobattery Minerals supports Uppsala University’s Vinnova application for new scientific approach to extracting battery minerals

· Project on new and modern industrialised methods to extract Rare Earth Elements (REE) · REE rich black shales from Eurobattery Minerals exploration project in Fetsjön will be part of the project · Eurobattery Minerals will support with funding as part of the Vinnova application submitted by the Uppsala University with final approval at the beginning of spring 2021. Eurobattery Minerals AB (Nordic Growth Market: “BAT”), a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, announced an extension

Mycronic receives order for a SLX and a Prexision Lite 8 Evo mask writer

Mycronic has received an order from a customer in Asia for an SLX and a Prexision Lite 8 Evo mask writer, which will replace one of the customer’s older systems. The order has a total value of between USD 12–14 million. Delivery of the SLX system is scheduled for the second quarter of 2021, while delivery of the Prexision Lite 8 Evo system is scheduled for the third quarter of the same year.The SLX laser mask writer was launched in October 2019 to meet rising demand for photomasks for the semiconductor industry, which is driven by long-term trends, and to meet the future need for

Kemira updates its financial targets and dividend policy

Kemira Oyj, Other information disclosed according to the rules of the Exchange, November 19, 2020 at 9.00 am (EET) Kemira updates its financial targets and dividend policy Kemira’s Board of Directors has approved the company’s updated financial targets, which will take effect immediately. Kemira’s target for operative EBITDA margin has been updated to 15-18% (previously 15-17%), while other financial targets remain unchanged. Kemira’s updated financial targets are as follows:-Above-the-market growth (unchanged)-Operative EBITDA margin of 15-18% (previously 15-17%)-Gearing

Finnish fintech Saldo Finance expands in Lithuania

Saldo Finance Plc               Press release 19 November 2020 at 9.00 a.m. EETSaldo Finance Plc, a Finnish fintech company creating responsible lending solutions, has announced plans to double its product development team in Vilnius over the next year. With 7 people already working in the company's Vilnius office, Saldo also expects to start lending operations in Lithuania in January of next year.   Established in 2006, Saldo is an international loan provider, offering flexible loans for both consumers and businesses. The company has developed a fully automated lending system, with

There are no items matching the current filter
There are no more items matching the current filter
Back to top